Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move- (CSE: $CNNA.C) (CSE: $HUGE.C) (TSX: $TGOD.TO) (NYSE: $CGC) (CSE: $AGRO.C)
Delta, Kelowna, BC –May 7, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/05071CNNA-HUGE-TGOD-CGC-AGRO.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast I look at a few of the day’s earlier announcements.
CannaOne Technologies (CSE: CNNA) gave a brief update on the soon-to-launch online CBD marketplace for Mexico in partnership with Manna Health Services SA de CV. CannaOne is currently negotiating final terms of the formal service agreement with Manna intended to be a revenue sharing arrangement subject to terms and conditions expected to be fully defined in the near-term. It is predicted that this online Mexican marketplace will begin operations sometime in the Fall of 2019 with such actual launch date dependent on when, and if, the Mexican authorities ultimately permit the import and sale of CBD products within Mexico.
CannaOne CEO Solomon Riby-Williams stated, "The Mexico CBD marketplace branded 'Casa CBD', will be the home of premium CBD products to service the massive Mexican market. BloomKit, our proprietary software, will provide the technology foundation for this online buying platform and it is with extreme confidence that we look ahead to acting in our role as a critical service provider in the future of Casa CBD."
Pertaining to the Mexico, according to Marijuana Moment, lawmakers plan to use the summer recess, which begins May 1 and runs through August 31, to rework legislation to legalize recreational marijuana throughout Mexico. This recess period is particularly important given that the Supreme Court has imposed an October deadline to develop a countrywide regulatory plan for cannabis and hemp.
FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) and Solarvest BioEnergy Inc. (TSX-V: SVS), a technology company that developed an algal-based flexible production platform capable of producing health products, announced today that they signed a definitive collaborative research and development agreement. Under the agreement, Solarvest will conduct research using its algal expression technology to develop pharmaceutical-grade cannabinoids. FSD Pharma and Solarvest have made investments into one another and FSD has the option to enter into an exclusive license arrangement over a subset of the project and receive royalty rights over all of the products that result from the project.
Solarvest will carry out a research project using its algal expression system for the purpose of developing a proof of concept that algae can express pharmaceutical-grade cannabinoids. FSD and Solarvest have allocated an initial budget of $1,000,000 for the CBD research project, over a two-year period, and created a joint scientific review committee to assess progress of the project against budgets and timelines.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) announced today that the Company expects to release its first quarter 2019 earnings on Tuesday, May 14, 2019, after market close. The Company will hold a conference call conducted by Brian Athaide, Chief Executive Officer, and Sean Bovingdon, Chief Financial Officer, at 9:00 am Eastern Time on May 15, 2019, to discuss first quarter 2019 results and future outlook.
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) introduced Spectrum Therapeutics, a new global brand that will encompass all of the Company's ongoing commercial medical and clinical research operations including Spectrum Cannabis, Canopy Health Innovations (CHI), and the most recent addition to Canopy Growth's medical portfolio, Bionorica SE-founded C3 Cannabinoid Compound Company ("C3"), a European leader in cannabinoid-based medical therapies.
Incorporating these entities into one unified ecosystem will integrate the Company's medical efforts as one global healthcare enterprise. Spectrum Therapeutics now encompasses the production and distribution of full-spectrum and single cannabinoid medical cannabis products; industry-leading education, resources and support for patients and healthcare practitioners; as well as pre-clinical and clinical research and the development of cannabinoid-based medicines.
The recent acquisition of C3 will allow Spectrum Therapeutics to continue to advance leadership in medical cannabis globally by further expanding its ability to empower physicians in Europe and around the world with the knowledge and therapies drawn from a full range of cannabinoid-based medicines. This includes dronabinol, C3's cannabinoid pharmaceutical drug available in Germany, Austria, Switzerland, and Denmark. Dronabinol, while integrated into the Spectrum Therapeutics commercial offering, will continue to be marketed under C3's established and recognized branding, Bionorica Ethics.
Agrios Global Holdings Ltd. (CSE: AGRO) (OTCQB: AGGHF) announced that Yunnan Hua Ma Biological Development Co. Ltd. ("HMB"), a subsidiary of Agrios Asia Holdings Limited has recently obtained an Industrial Hemp Cultivation Permit in Yunnan Province, the People's Republic of China.
The Permit, grants HMB rights to cultivate industrial hemp in the region and to transport industrial hemp seeds, hemp raw materials, hemp stalk and their processed products. Yunnan was the first province in China to allow hemp cultivation in 2010 and has since issued licences for hemp cultivation on more than 220,000 mu (36,300+ acres).
HMB intends to grow 200mu (1mu = 667m2) of Industrial hemp in the 2019 season. A smaller first crop is adequate to continue HMB's development of hemp cultivation and to supply raw materials for current biotechnology research which is focused on utilizing hemp fibers as a bio-degradable alternative for the manufacture of single use disposable utensils.
Both Federal and Provincial authorities from Yunnan's capital, Kunming, have also granted HMB an Import & Export Permit allowing for the direct import and export of goods, internationally as allowable by China customs. In addition, a Food Trading Permit, allows HMB to buy and sell pre-packaged and non-packaged food products, including speciality foods, health foods and nutraceuticals, through both retail and wholesale market channels.
HMB's acquisition of the three new permits for cultivation, import/export and food trading provides an exciting opportunity for Agrios' subsidiaries to join in the rapidly expanding trade of hemp products in and out of China. China's exports of industrial hemp products are projected to grow to US $1.5 billion by 2020, according to New Frontier Data, an independent, technology-driven analytics company specializing in the cannabis industry.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
